Search Results - "Janson, Anneke"

Refine Results
  1. 1

    Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy by Beekman, Chantal, Janson, Anneke A, Baghat, Aabed, van Deutekom, Judith C, Datson, Nicole A

    Published in PloS one (11-04-2018)
    “…Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by progressive weakness of the skeletal and cardiac muscles. This X-linked disorder…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms by Aartsma-Rus, Annemieke, van Vliet, Laura, Hirschi, Marscha, Janson, Anneke AM, Heemskerk, Hans, de Winter, Christa L, de Kimpe, Sjef, van Deutekom, Judith CT, 't Hoen, Peter AC, van Ommen, Gert-Jan B

    Published in Molecular therapy (01-03-2009)
    “…Antisense oligonucleotides (AONs) can interfere with mRNA processing through RNase H–mediated degradation, translational arrest, or modulation of splicing. The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients by Aartsma-Rus, Annemieke, Janson, Anneke A.M., Kaman, Wendy E., Bremmer-Bout, Mattie, den Dunnen, Johan T., Baas, Frank, van Ommen, Gert-Jan B., van Deutekom, Judith C.T.

    Published in Human molecular genetics (15-04-2003)
    “…The dystrophin deficiency leading to the severely progressing muscle degeneration in Duchenne muscular dystrophy (DMD) patients is caused by frame-shifting…”
    Get full text
    Journal Article
  6. 6

    Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy by Aartsma-Rus, Annemieke, Janson, Anneke A M, van Ommen, Gert-Jan B, van Deutekom, Judith C T

    Published in BMC medical genetics (05-07-2007)
    “…Antisense-mediated exon skipping is currently one of the most promising therapeutic approaches for Duchenne muscular dystrophy (DMD). Using antisense…”
    Get full text
    Journal Article
  7. 7

    DMD transcript imbalance determines dystrophin levels by Spitali, Pietro, Bergen, Janneke C., Verhaart, Ingrid E. C., Wokke, Beatrijs, Janson, Anneke A. M., Eijnde, Rani, Dunnen, Johan T., Laros, Jeroen F. J., Verschuuren, Jan J. G. M., Hoen, Peter A. C. 't, Aartsma‐Rus, Annemieke

    Published in The FASEB journal (01-12-2013)
    “…Duchenne and Becker muscular dystrophies are caused by out‐of‐frame and in‐frame mutations, respectively, in the dystrophin encoding DMD gene. Molecular…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More Sense by Aartsma-Rus, Annemieke, Janson, Anneke A.M., Kaman, Wendy E., Bremmer-Bout, Mattie, van Ommen, Gert-Jan B., den Dunnen, Johan T., van Deutekom, Judith C.T.

    Published in American journal of human genetics (01-01-2004)
    “…Dystrophin deficiency, which leads to severe and progressive muscle degeneration in patients with Duchenne muscular dystrophy (DMD), is caused by frameshifting…”
    Get full text
    Journal Article
  10. 10

    Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides by Bremmer-Bout, Mattie, Aartsma-Rus, Annemieke, de Meijer, Emile J, Kaman, Wendy E, Janson, Anneke A M, Vossen, Rolf H A M, van Ommen, Gert-Jan B, den Dunnen, Johan T, van Deutekom, Judith C T

    Published in Molecular therapy (01-08-2004)
    “…The therapeutic potential of frame-restoring exon skipping by antisense oligonucleotides (AONs) has recently been demonstrated in cultured muscle cells from a…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy by Aartsma-Rus, Annemieke, Bremmer-Bout, Mattie, Janson, Anneke A.M, den Dunnen, Johan T, van Ommen, Gert-Jan B, van Deutekom, Judith C.T

    Published in Neuromuscular disorders : NMD (01-10-2002)
    “…Duchenne muscular dystrophy is primarily caused by frame-disrupting mutations in the Duchenne muscular dystrophy gene which abort dystrophin synthesis. We have…”
    Get full text
    Journal Article
  13. 13

    Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells by van Deutekom, J C, Bremmer-Bout, M, Janson, A A, Ginjaar, I B, Baas, F, den Dunnen, J T, van Ommen, G J

    Published in Human molecular genetics (15-07-2001)
    “…Due to frame-shifting mutations in the DMD gene that cause dystrophin deficiency, Duchenne muscular dystrophy (DMD) patients suffer from lethal muscle…”
    Get full text
    Journal Article
  14. 14

    Use of capillary Western immunoassay by Beekman, Chantal, Janson, Anneke A, Baghat, Aabed, van Deutekom, Judith C, Datson, Nicole A

    Published in PloS one (11-04-2018)
    “…Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by progressive weakness of the skeletal and cardiac muscles. This X-linked disorder…”
    Get full text
    Journal Article
  15. 15

    Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites by Aartsma-Rus, Annemieke, De Winter, Christa L, Janson, Anneke A M, Kaman, Wendy E, Van Ommen, Gert-Jan B, Den Dunnen, Johan T, Van Deutekom, Judith C T

    Published in Oligonucleotides (01-12-2005)
    “…As small molecule drugs for Duchenne muscular dystrophy (DMD), antisense oligonucleotides (AONs) have been shown to restore the disrupted reading frame of DMD…”
    Get more information
    Journal Article
  16. 16

    HLA-Class II-Associated Control of Antigen Recognition by T Cells in Leprosy: A Prominent Role for the 30/31-kDa Antigens by Thole, Jelle E. R, Janson, Anneke A. M, Cornelisse, Yolanthe, Schreuder, Geziena M. T, Wieles, Brigitte, Naafs, Ben, de Vries, Rene R. P, Ottenhoff, Tom H. M

    Published in The Journal of immunology (1950) (01-06-1999)
    “…The recognition of 16 mycobacterial Ags by a panel of T cell lines from leprosy patients and healthy exposed individuals from an endemic population was…”
    Get full text
    Journal Article
  17. 17

    A Mycobacterium leprae--Specific Human T Cell Epitope Cross-Reactive with an HLA-DR2 Peptide by Anderson, D. C., Wim C. A. Van Schooten, Barry, Michael E., Anneke A. M. Janson, Buchanan, Tom M., René R. P. De Vries

    “…Mycobacterium leprae induces T cell reactivity and protective immunity in the majority of exposed individuals, but the minority that develop leprosy exhibit…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groES by Rinke de Wit, T F, Bekelie, S, Osland, A, Miko, T L, Hermans, P W, van Soolingen, D, Drijfhout, J W, Schöningh, R, Janson, A A, Thole, J E

    Published in Molecular microbiology (01-07-1992)
    “…In contrast to other bacterial species, mycobacteria were thus far considered to contain groEL and groES genes that are present on separate loci on their…”
    Get more information
    Journal Article
  20. 20

    A Mycobacterium leprae-specific gene encoding an immunologically recognized 45 kDa protein by Rinke de Wit, T F, Clark-Curtiss, J E, Abebe, F, Kolk, A H, Janson, A A, van Agterveld, M, Thole, J E

    Published in Molecular microbiology (01-11-1993)
    “…By screening a Mycobacterium leprae lambda gt11 expression library with a serum from an Ethiopian lepromatous leprosy (LL) patient a clone was isolated (LL4)…”
    Get more information
    Journal Article